Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.
about
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity.Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition.Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials.Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
P2860
Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neurocognitive, Neuroprotectiv ...... tic Outcomes in Schizophrenia.
@en
type
label
Neurocognitive, Neuroprotectiv ...... tic Outcomes in Schizophrenia.
@en
prefLabel
Neurocognitive, Neuroprotectiv ...... tic Outcomes in Schizophrenia.
@en
P2860
P1433
P1476
Neurocognitive, Neuroprotectiv ...... utic Outcomes in Schizophrenia
@en
P2093
Mohammad M Khan
P2860
P2888
P304
P356
10.1007/S40263-016-0343-6
P577
2016-07-01T00:00:00Z